May 24, 2026
Headlines

Divi’s Laboratories

Divi's Laboratories Announces 1500% Dividend Following Strong Q4 FY26 Financial Performance

Divi’s Laboratories Announces 1500% Dividend Following Strong Q4 FY26 Financial Performance

Business News Desk03 mins mins

Divi’s Laboratories, a global leader in active pharmaceutical ingredients (APIs), reported a robust financial performance for the fourth quarter of fiscal year 2025-26, highlighted by a 13.4% year-on-year increase in profit after tax (PAT) to Rs 751 crore. Alongside these earnings, the company’s board recommended a significant dividend of Rs 30 per share—representing a 1500%…

Read More
Divi's Laboratories Reports 13% Profit Growth in Q4, Surpassing Market Expectations

Divi’s Laboratories Reports 13% Profit Growth in Q4, Surpassing Market Expectations

Business News Desk02 mins mins

Hyderabad-based pharmaceutical giant Divi’s Laboratories reported a 13% year-on-year increase in net profit for the fourth quarter ending March 2026, successfully outpacing analyst expectations. The company announced its financial results this week, revealing a robust performance despite facing headwinds in operational margins. Financial Performance and Dividend Announcement Divi’s Laboratories posted a net profit of ₹538…

Read More